It is difficult to track where the new money is being spent, but, as the evidence that the committee took before the summer demonstrated, much of the additional investment is likely to be absorbed by cost pressures such as pay modernisation and the rising cost of drugs.On page 17 of the report, in exhibit 7, we summa...